Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 244.00
Bid: 242.00
Ask: 246.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.653%)
Open: 244.00
High: 0.00
Low: 0.00
Prev. Close: 244.00
MAJE Live PriceLast checked at -
Majedie is an Investment Trust

To maximise total shareholder return whilst increasing dividends by more than the rate of inflation over the long-term by investing in securities of publicly quoted companies worldwide, though it may invest in unquoted securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Jul 2020 15:54

RNS Number : 7614R
Majedie Investments PLC
01 July 2020
 

1 July 2020

Majedie Investments PLC

 

Directorate Changes

 

The Board is delighted to announce that with effect from 1 July 2020, Christopher Getley and Richard Killingbeck have been appointed to the Board as Non-Executive Directors. They have also been appointed as members of the Audit, Remuneration, Management Engagement and Nomination Committees from this date.

 

The Board also announces the retirement of Paul Gadd, who has served on the Board since 2009, with effect from 31 July 2020. The Board would like to thank him for his wise counsel as a member of the Board and also as Chairman of the Remuneration and Management Engagement Committees. Upon Mr Gadd's resignation, Jane Lewis will become Chairman of the Remuneration Committee and David Henderson will become Chairman of the Management Engagement Committee.

 

Mr Getley has extensive knowledge of the investment industry as a Partner and Fund Manager at Cazenove and as a Director of Morgan Grenfell Asset Management. Subsequently, he was CEO of Westhouse Securities, an institutional stockbroker. He is currently Executive Chairman of AgPlus Diagnostics Limited and Non-Executive Chairman of Masawara PLC, a Southern Africa focussed investment company.

 

Mr Killingbeck has over 35 years' experience in the financial services sector, initially as a fund manager and latterly in a number of senior management roles within the wealth management sector. He was previously Chief Executive Officer of WH Ireland Group PLC and is currently Managing Director of Harris Allday, a subsidiary of EFG Private Bank. He retired as the Non-Executive Chairman of Bankers Investment Trust PLC in 2019 and is currently a trustee of the London Stock Exchange Benevolent Fund.

 

There is no information concerning Mr Getley or Mr Killingbeck that is required to be disclosed pursuant to Listing Rule 9.6.13R (2) to (6) inclusive and the Board considers them to be independent on appointment in accordance with the AIC Code of Corporate Governance. Mr Getley and Mr Killingbeck currently own 33,830 and 20,000 shares in the Company respectively.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFLFESDFILIII
Date   Source Headline
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSDividend Declaration
25th Apr 20245:05 pmRNSFinal Net Asset Value
25th Apr 20245:03 pmRNSMid-Month Estimated Net Asset Value
10th Apr 20245:47 pmRNSEstimated Net Asset Value
2nd Apr 202411:27 amRNSTotal Voting Rights
25th Mar 20245:17 pmRNSHolding(s) in Company
25th Mar 20245:12 pmRNSFinal Net Asset Value
25th Mar 20245:10 pmRNSMid-Month Estimated Net Asset Value
12th Mar 202410:08 amRNSDirectorate Change
11th Mar 20245:39 pmRNSEstimated Net Asset Value
1st Mar 20242:48 pmRNSTotal Voting Rights
26th Feb 20246:15 pmRNSNet Asset Value(s)
26th Feb 20246:15 pmRNSNet Asset Value(s)
22nd Feb 20245:11 pmRNSHolding(s) in Company
1st Feb 202411:11 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSDividend Declaration
25th Jan 20245:52 pmRNSNet Asset Value(s)
25th Jan 20245:52 pmRNSNet Asset Value(s)
18th Jan 202412:46 pmRNSDirector Declaration
17th Jan 20244:17 pmRNSResult of AGM
10th Jan 202412:58 pmRNSNet Asset Value(s)
4th Jan 20242:30 pmRNSHolding(s) in Company
2nd Jan 20243:50 pmRNSResults analysis from Kepler Trust Intelligence
2nd Jan 202412:59 pmRNSTotal Voting Rights
22nd Dec 202312:42 pmRNSNet Asset Value(s)
22nd Dec 202312:41 pmRNSNet Asset Value(s)
18th Dec 20234:06 pmRNSBlock listing Interim Review
18th Dec 20237:00 amRNSAnnual Financial Report
11th Dec 20235:36 pmRNSNet Asset Value(s)
1st Dec 202311:47 amRNSTotal Voting Rights
27th Nov 20232:44 pmRNSNet Asset Value(s)
24th Nov 20235:19 pmRNSNet Asset Value(s)
17th Nov 20234:56 pmRNSHolding(s) in Company
10th Nov 20233:35 pmRNSNet Asset Value(s)
8th Nov 20237:05 amRNSBoard role change
8th Nov 20237:00 amRNSDividend Declaration
1st Nov 202310:42 amRNSTotal Voting Rights
25th Oct 20236:25 pmRNSNet Asset Value(s)
25th Oct 20236:25 pmRNSNet Asset Value(s)
10th Oct 20235:53 pmRNSNet Asset Value(s)
2nd Oct 202311:32 amRNSTotal Voting Rights
25th Sep 20235:14 pmRNSNet Asset Value(s)
25th Sep 20235:13 pmRNSNet Asset Value(s)
11th Sep 20235:45 pmRNSNet Asset Value(s)
1st Sep 202311:42 amRNSTotal Voting Rights
30th Aug 202312:59 pmRNSHolding(s) in Company
25th Aug 202312:59 pmRNSNet Asset Value(s)
25th Aug 202312:58 pmRNSNet Asset Value(s)
10th Aug 20236:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.